Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 10Sanofi-Aventis Canada Inc.
02 15Bayer Inc.
01 32376379
02 22519875
03 22586735
04 22598711
05 22654510
06 22693152
07 42970315
08 43007276
09 43137326
01 25AFLIBERCEPT
01 25SOLUTION
01 11935-12-10
02 21936-12-01
03 32020-05-23
04 22024-06-04
05 22025-12-02
06 22026-03-22
07 22027-06-14
08 22028-07-02
09 32035-12-10
10 62036-12-01
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2024-06-04
Date Granted : 2014-01-14
Brand Name : ZALTRAP
Patent Number : 2519875
Filing Date : 2004-06-04
Strength per Unit : 100 mg / vial
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2024-06-04
Date Granted : 2014-01-14
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2020-05-23
Date Granted : 2007-08-07
Brand Name : ZALTRAP
Patent Number : 2376379
Filing Date : 2000-05-23
Strength per Unit : 100 mg / vial
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2020-05-23
Date Granted : 2007-08-07
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2025-12-02
Date Granted : 2014-08-12
Brand Name : ZALTRAP
Patent Number : 2586735
Filing Date : 2005-12-02
Strength per Unit : 100 mg / vial
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2025-12-02
Date Granted : 2014-08-12
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2020-05-23
Date Granted : 2007-08-07
Brand Name : ZALTRAP
Patent Number : 2376379
Filing Date : 2000-05-23
Strength per Unit : 200 mg / vial
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2020-05-23
Date Granted : 2007-08-07
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2024-06-04
Date Granted : 2014-01-14
Brand Name : ZALTRAP
Patent Number : 2519875
Filing Date : 2004-06-04
Strength per Unit : 200 mg / vial
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2024-06-04
Date Granted : 2014-01-14
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2025-12-02
Date Granted : 2014-08-12
Brand Name : ZALTRAP
Patent Number : 2586735
Filing Date : 2005-12-02
Strength per Unit : 200 mg / vial
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2025-12-02
Date Granted : 2014-08-12
Patent Expiration Date : 2020-05-23
Date Granted : 2007-08-07
Brand Name : EYLEA
Patent Number : 2376379
Filing Date : 2000-05-23
Strength per Unit : 2mg / 0.05 mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVITREAL
Patent Expiration Date : 2020-05-23
Date Granted : 2007-08-07
Patent Expiration Date : 2027-06-14
Date Granted : 2015-03-17
Brand Name : EYLEA
Patent Number : 2654510
Filing Date : 2007-06-14
Strength per Unit : 2mg / 0.05 mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVITREAL
Patent Expiration Date : 2027-06-14
Date Granted : 2015-03-17
Patent Expiration Date : 1935-12-10
Date Granted : 2023-08-22
Brand Name : EYLEA HD
Patent Number : 2970315
Filing Date : 2015-12-10
Strength per Unit : 8mg / 0.07mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVITREAL
Patent Expiration Date : 1935-12-10
Date Granted : 2023-08-22
Patent Expiration Date : 1936-12-01
Date Granted : 2021-12-28
Brand Name : EYLEA HD
Patent Number : 3007276
Filing Date : 2016-12-01
Strength per Unit : 8mg / 0.07mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVITREAL
Patent Expiration Date : 1936-12-01
Date Granted : 2021-12-28
